Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia

Daytime sleepiness is a commonly reported adverse effect associated with psychotropic agents that may impair cognitive performance and functioning. The objective of this post-hoc analysis was to evaluate the long-term effects of lurasidone and quetiapine XR on daytime sleepiness and neurocognitive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey, Philip D., Siu, Cynthia O., Loebel, Antony D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514294/
https://www.ncbi.nlm.nih.gov/pubmed/28740811
http://dx.doi.org/10.1016/j.scog.2016.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514294/
https://www.ncbi.nlm.nih.gov/pubmed/28740811
http://dx.doi.org/10.1016/j.scog.2016.05.002

Ejemplares similares